Literature DB >> 31408161

HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study.

Seung-Hwan Lee1,2, Hun-Sung Kim1,2, Yong-Moon Park3, Hyuk-Sang Kwon4, Kun-Ho Yoon1,2, Kyungdo Han5, Mee Kyoung Kim4.   

Abstract

CONTEXT: The bidirectional relationship between low high-density lipoprotein cholesterol (HDL-C) and glucose intolerance is well established. Recent studies suggested an association of lipid variability with various health outcomes.
OBJECTIVE: To investigate the combined effect of HDL-C levels and their variability on the risk of diabetes.
DESIGN: A population-based cohort study. SETTING AND PARTICIPANTS: In all, 5,114,735 adults without known diabetes in the Korean National Health Insurance System cohort who underwent three or more health examinations from 2009 to 2013 were included. Visit-to-visit HDL-C variability was calculated using variability independent of the mean (VIM) and the coefficient of variation (CV). Low mean and high variability groups were defined as the lowest and highest quartiles of HDL-C mean and variability, respectively. MAIN OUTCOME MEASURES: Newly developed diabetes.
RESULTS: There were 122,192 cases (2.4%) of incident diabetes during the median follow-up of 5.1 years. Lower mean or higher variability of HDL-C was associated with higher risk of diabetes in a stepwise manner, and an additive effect of the two measures was noted. In the multivariable-adjusted model, the hazard ratios and 95% CIs for incident diabetes were 1.20 (1.18 to 1.22) in the high mean/high VIM group, 1.35 (1.33 to 1.37) in the low mean/low VIM group, and 1.40 (1.38 to 1.42) in the low mean/high VIM group compared with the high mean/low VIM group. Similar results were observed when modeling the variability using CV and in various subgroup analyses.
CONCLUSIONS: Low mean and high variability in HDL-C were independent predictors of diabetes with an additive effect. Both elevating and stabilizing HDL-C may be important goals for reducing diabetes risk.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31408161     DOI: 10.1210/jc.2019-01080

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose-response meta-analysis of cohort studies.

Authors:  Raymond Pranata; Ian Huang; Michael Anthonius Lim; Rachel Vania
Journal:  Endocrine       Date:  2021-06-04       Impact factor: 3.633

2.  Increased high‑density lipoprotein‑oxidant index in ischemic stroke patients.

Authors:  Deepa Damayanthi; Soumya Krishnamoorthy; P N Sylaja; Srinivas Gopala
Journal:  Biomed Rep       Date:  2022-09-14

3.  Non-linear relationship between high-density lipoprotein cholesterol and incident diabetes mellitus: a secondary retrospective analysis based on a Japanese cohort study.

Authors:  Changchun Cao; Haofei Hu; Xiaodan Zheng; Xiaohua Zhang; Yulong Wang; Yongcheng He
Journal:  BMC Endocr Disord       Date:  2022-06-18       Impact factor: 3.263

Review 4.  Effects of Cardiovascular Risk Factor Variability on Health Outcomes.

Authors:  Seung-Hwan Lee; Mee Kyoung Kim; Eun-Jung Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

5.  Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: a cross-sectional survey in Chinese elderly adults.

Authors:  Xiao-Wei Ji; Guo-Shan Feng; Hong-Lan Li; Jie Fang; Jing Wang; Qiu-Ming Shen; Li-Hua Han; Da-Ke Liu; Yong-Bing Xiang
Journal:  Ann Transl Med       Date:  2021-01

Review 6.  High Density Lipoproteins and Diabetes.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

7.  Associations of visit-to-visit variabilities and trajectories of serum lipids with the future probability of type 2 diabetes mellitus.

Authors:  Qian Sun; Jingchao Liu; Lei Wu; Yue Sun; Jianrong Jin; Sudan Wang; Jing Wu; Yang Jing; Hui Zhou; Chen Dong
Journal:  Lipids Health Dis       Date:  2021-11-27       Impact factor: 3.876

8.  Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes.

Authors:  Seung-Hwan Lee; Kyungdo Han; Hyuk-Sang Kwon; Mee Kyoung Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

9.  Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30-Day Mortality in the General Population.

Authors:  Seung-Hwan Lee; Kyungdo Han; Hyuk-Sang Kwon; Kun-Ho Yoon; Mee Kyoung Kim
Journal:  J Am Heart Assoc       Date:  2020-11-06       Impact factor: 5.501

10.  Increased Visit-to-Visit Liver Enzyme Variability Is Associated with Incident Diabetes: A Community-Based 12-Year Prospective Cohort Study.

Authors:  Kyuhoon Bang; Ji Eun Jun; In-Kyung Jeong; Kyu Jeung Ahn; Ho Yeon Chung; You-Cheol Hwang
Journal:  Diabetes Metab J       Date:  2021-03-17       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.